Abstract
Alpha-blockers have been established as medical expulsive therapy for urolithiasis. We aimed to assess the effect of tamsulosin and doxazosin as adjunctive therapy following SWL for renal calculi. We prospectively included 150 patients who underwent up to four SWL sessions for renal stones from June 2008 to 2009. Patients were randomized into three groups of 50 patients each, group A (phloroglucinol 240 mg daily), group B (tamsulosin 0.4 mg once daily plus phloroglucinol), and group C (doxazosin 4 mg plus phloroglucinol). The treatment continued up to maximum 12 weeks. Patients were evaluated for stone expulsion, colic attacks, amount of analgesics and side-effects of alpha-blockers. There were no significant differences between the groups regarding stone expulsion rates (84; 92 and 90%, respectively). The mean expulsion time of tamsulosin was significantly shorter than both control group (p = 0.002) and doxazosin (p = 0.026). Both number of colic episodes and analgesic dosage were significantly lower with tamsulosin as compared to control and doxazosin. Steinstrasse was encountered in 10 (6.7%) patients with no significant difference between the groups. 16 patients on tamsulosin and 21 on doxazosin experienced adverse effects related to postural hypotension. Moreover, 2 (4%) patients in the tamsulosin group reported ejaculatory complaints. In conclusion, adjunction of tamsulosin or doxazosin after SWL for renal calculi decreases the time for stone expulsion, amount of the analgesics and number colic episodes. There was no benefit regarding the overall stone expulsion rate. The side-effects of these agents are common and should be weighted against the benefits of their usage.
Similar content being viewed by others
References
Curhan GC (2007) Epidemiology of stone disease. Urol Clin North Am 34:287–293
Türk C, Knoll T, Petrik A, Sarica K, Straub M, Seitz C (2010) Guidelines on urolithiasis. European Association of Urology, UK
Kim TH, Oh SY, Moon YT (2008) The effect of tamsulosin on expulsion of ureteral stones after extracorporeal shock wave lithotripsy. Korean J Urol 49:1100–1104
Seitz C, Liatsikos E, Porpiglia F, Tiselius HG, Zwergel U (2009) Medical therapy to facilitate the passage of stones: what is the evidence? Eur Urol 56(3):455–471
Zheng S, Liu LR, Yuan HC, Wei Q (2010) Tamsulosin as adjunctive treatment after shockwave lithotripsy in patients with upper urinary tract stones: a systematic review and meta-analysis. Scand J Urol Nephrol 44(6):425–432
Wang CJ, Huang SW, Chang CH (2009) Adjunctive medical therapy with an alpha-1A-specific blocker after shock wave lithotripsy of lower ureteral stones. Urol Int 82(2):166–169
Zehri AA, Ather MH, Abbas F, Biyabani SR (2010) Preliminary study of efficacy of doxazosin as a medical expulsive therapy of distal ureteric stones in a randomized clinical trial. Urology 75(6):1285–1288
Schuler TD, Shahani R, Honey RJ, Pace KT (2009) Medical expulsive therapy as an adjunct to improve shockwave lithotripsy outcomes: a systematic review and meta-analysis. J Endourol 23(3):387–393
Madaan S, Joyce AD (2007) Limitations of extracorporeal shock wave lithotripsy. Curr Opin Urol 17(2):109–113
Bhagat SK, Chacko NK, Kekre NS, Gopalakrishnan G, Antonisamy B, Devasia A (2007) Is there a role for tamsulosin in shock wave lithotripsy for renal and ureteral calculi? J Urol 177(6):2185–2188
Dellabella M, Milanese G, Muzzonigro G (2005) Randomized trial of the efficacy of tamsulosin, nifedipine and phloroglucinol in medical expulsive therapy for distal ureteral calculi. J Urol 174(1):167–172
Rajpathy J, Aswathaman K, Sinha M, Subramani S, Gopalakrishnan G, Kekre NS (2008) An in vitro study on human ureteric smooth muscle with the alpha1-adrenoceptor subtype blocker, tamsulosin. BJU Int 102(11):1743–1745
Naja V, Agarwal MM, Mandal AK, Singh SK, Mavuduru R, Kumar S, Acharya NC, Gupta N (2008) Tamsulosin facilitates earlier clearance of stone fragments and reduces pain after shockwave lithotripsy for renal calculi: results from an open-label randomized study. Urology 72(5):1006–1011
Gravina GL, Costa AM, Ronchi P, Galatioto GP, Angelucci A, Castellani D, Narcisi F, Vicentini C (2005) Tamsulosin treatment increases clinical success rate of single extracorporeal shock wave lithotripsy of renal stones. Urology 66(1):24–28
Hussein MM (2010) Does tamsulosin increase stone clearance after shockwave lithotripsy of renal stones? A prospective, randomized controlled study. Scand J Urol Nephrol 44(1):27–31
Zhu Y, Duijvesz D, Rovers MM, Lock TM (2010) alpha-Blockers to assist stone clearance after extracorporeal shock wave lithotripsy: a meta-analysis. BJU Int 106(2):256–261
Yilmaz E, Batislam E, Basar MM, Tuglu D, Ferhat M, Basar H (2005) The comparison and efficacy of 3 different alpha1-adrenergic blockers for distal ureteral stones. J Urol 173(6):2010–2012
Tajari H, Pedram P, Keshtkar A et al (2009) The comparison between efficacy of tamsulosin and terazosin in alpha-adrenergic blockers after ESWL. Urology 74(Suppl 4A):S340
Micali S, Grande M, Sighinolfi MC, De Stefani S, Bianchi G (2007) Efficacy of expulsive therapy using nifedipine or tamsulosin, both associated with ketoprofene, after shock wave lithotripsy of ureteral stones. Urol Res 35(3):133–137
Gravas S, Tzortzis V, Karatzas A, Oeconomou A, Melekos MD (2007) The use of tamsulosin as adjunctive treatment after ESWL in patients with distal ureteral stone: do we really need it? Results from a randomised study. Urol Res 35(5):231–235
Agarwal MM, Naja V, Singh SK, Mavuduru R, Mete UK, Kumar S, Mandal AK (2009) Is there an adjunctive role of tamsulosin to extracorporeal shockwave lithotripsy for upper ureteric stones: results of an open label randomized nonplacebo controlled study. Urology 74(5):989–992
Falahatkar S, Khosropanah I, Vajary AD, Bateni ZH, Khosropanah D, Allahkhah A (2011) Is there a role for tamsulosin after shock wave lithotripsy in the treatment of renal and ureteral calculi? J Endourol 25(3):495–498
Sigala S, Dellabella M, Milanese G, Fornari S, Faccoli S, Palazzolo F, Peroni A, Mirabella G, Cunico SC, Spano P, Muzzonigro G (2005) Evidence for the presence of alpha1 adrenoceptor subtypes in the human ureter. Neurourol Urodyn 24(2):142–148
Cervenàkov I, Fillo J, Mardiak J, Kopecný M, Smirala J, Lepies P (2002) Speedy elimination of ureterolithiasis in lower part of ureters with the alpha 1-blocker—tamsulosin. Int Urol Nephrol 34(1):25–29
Ukhal MI, Malomuzh OI, Strashny V (1999) Administration of doxazosin for speedy elimination of stones from lower section of ureter. Eur Urol 35(Suppl 2):4–6
Liatsikos EN, Katsakiori PF, Assimakopoulos K, Voudoukis T, Kallidonis P, Constantinides C, Athanasopoulos A, Stolzenburg JU, Perimenis P (2007) Doxazosin for the management of distal-ureteral stones. J Endourol 21(5):538–541
Madbouly K, Sheir KZ, Elsobky E, Eraky I, Kenawy M (2002) Risk factors for the formation of a steinstrasse after extracorporeal shock wave lithotripsy: a statistical model. J Urol 167(3):1239–1242
Soyupek S, Armağan A, Koşar A, Serel TA, Hoşcan MB, Perk H, Oksay T (2005) Risk factors for the formation of a steinstrasse after shock wave lithotripsy. Urol Int 74(4):323–325
Resim S, Ekerbicer HC, Ciftci A (2005) Role of tamsulosin in treatment of patients with steinstrasse developing after extracorporeal shock wave lithotripsy. Urology 66(5):945–948
Moursy E, Gamal WM, Abuzeid A (2010) Tamsulosin as an expulsive therapy for steinstrasse after extracorporeal shock wave lithotripsy: a randomized controlled study. Scand J Urol Nephrol 44(5):315–319
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Zaytoun, O.M., Yakoubi, R., Zahran, A.R.M. et al. Tamsulosin and doxazosin as adjunctive therapy following shock-wave lithotripsy of renal calculi: randomized controlled trial. Urol Res 40, 327–332 (2012). https://doi.org/10.1007/s00240-011-0410-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00240-011-0410-x